ATE353335T1 - Einkettige antikörper gegen eine p53 mutante - Google Patents

Einkettige antikörper gegen eine p53 mutante

Info

Publication number
ATE353335T1
ATE353335T1 AT01914142T AT01914142T ATE353335T1 AT E353335 T1 ATE353335 T1 AT E353335T1 AT 01914142 T AT01914142 T AT 01914142T AT 01914142 T AT01914142 T AT 01914142T AT E353335 T1 ATE353335 T1 AT E353335T1
Authority
AT
Austria
Prior art keywords
mutant
single chain
antibodies against
chain antibodies
scfv
Prior art date
Application number
AT01914142T
Other languages
English (en)
Inventor
Beka Solomon
Gerald Cohen
Dimitri Govorko
Original Assignee
Univ Ramot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ramot filed Critical Univ Ramot
Application granted granted Critical
Publication of ATE353335T1 publication Critical patent/ATE353335T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT01914142T 2000-03-16 2001-03-09 Einkettige antikörper gegen eine p53 mutante ATE353335T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/526,738 US6630584B1 (en) 2000-03-16 2000-03-16 Single chain antibody against mutant p53

Publications (1)

Publication Number Publication Date
ATE353335T1 true ATE353335T1 (de) 2007-02-15

Family

ID=24098588

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01914142T ATE353335T1 (de) 2000-03-16 2001-03-09 Einkettige antikörper gegen eine p53 mutante

Country Status (6)

Country Link
US (2) US6630584B1 (de)
EP (1) EP1272609B1 (de)
AT (1) ATE353335T1 (de)
AU (1) AU2001239517A1 (de)
DE (1) DE60126482T2 (de)
WO (1) WO2001068801A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630584B1 (en) * 2000-03-16 2003-10-07 Ramot At Tel-Aviv University Ltd. Single chain antibody against mutant p53
US7799556B2 (en) * 2004-06-17 2010-09-21 George Dacai Liu System and method for antigen structure-independent detection of antigens captured on antibody arrays
US20060263837A1 (en) * 2004-06-17 2006-11-23 Liu George D Immunoassay system and method for detection of antigens
CN101035554A (zh) * 2004-08-23 2007-09-12 维兹曼科学研究所耶达研究与发展有限公司 介导应激反应的肽抑制剂
WO2006100681A2 (en) 2005-03-25 2006-09-28 Ramot At Tel Aviv University Ltd. Human synthetic single-chain antibodies directed against the common epitope of mutant p53 and their uses
WO2007056352A2 (en) 2005-11-07 2007-05-18 The Scripps Research Institute Compositions and methods for controlling tissue factor signaling specificity
EP2313435A4 (de) * 2008-07-01 2012-08-08 Aveo Pharmaceuticals Inc An den fibroblastenwachstumsfaktorrezeptor 3 (fgfr3) bindende proteine
GB2482536B (en) 2010-08-05 2013-07-24 Hera Pharmaceuticals Inc Expression of antibody or a fragment thereof in lactobacillus
EP2715350B1 (de) 2011-05-23 2017-09-27 Yeda Research and Development Co. Ltd. Verwendung einer akt-phosphorylierung als biomarker zur prognose neurodegenerativer erkrankungen und zu ihrer behandlung
WO2014093417A1 (en) 2012-12-12 2014-06-19 University Of Virginia Patent Foundation Compositions and methods for regulating erythropoiesis
EP2958584A1 (de) * 2013-02-20 2015-12-30 Yeda Research and Development Co., Ltd. Gegen mutante p53-exprimierende zellen gerichtete interferonbehandlung
WO2016081897A1 (en) * 2014-11-21 2016-05-26 University of the Sciences of Philadelphia COMPOSITIONS AND METHODS OF USING THERAPEUTIC p53 PEPTIDES AND ANALOGUES
AU2016235251B2 (en) * 2015-03-23 2022-03-17 The Johns Hopkins University HLA-restricted epitopes encoded by somatically mutated genes
GB201617564D0 (en) 2016-10-17 2016-11-30 Agency For Science Technology And Research And National University Of Singapore And Singapore Health Anti-p53 antibodies
JP7381345B2 (ja) 2017-05-16 2023-11-15 ザ・ジョンズ・ホプキンス・ユニバーシティ Ｍａｎａボディおよび使用方法
CN113528467B (zh) * 2021-06-24 2023-12-01 新乡学院 一种靶向性双展示噬菌体及其制备方法和应用
CA3234720A1 (en) * 2021-10-08 2023-04-13 Sola Biosciences Llc Compositions and methods for the treatment of p53-mediated cancers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5618920A (en) * 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
US5258498A (en) * 1987-05-21 1993-11-02 Creative Biomolecules, Inc. Polypeptide linkers for production of biosynthetic proteins
US5091513A (en) * 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
AU1211895A (en) * 1993-11-22 1995-06-13 Onyx Pharmaceuticals P53-binding polypeptides and polynucleotides encoding same
FR2755144B1 (fr) * 1996-10-29 1998-11-27 Rhone Poulenc Rorer Sa Fragments d'anticorps a chaine unique anti-p53 et utilisation
US20020155114A1 (en) * 1998-08-31 2002-10-24 James D. Marks Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
US6630584B1 (en) 2000-03-16 2003-10-07 Ramot At Tel-Aviv University Ltd. Single chain antibody against mutant p53

Also Published As

Publication number Publication date
AU2001239517A1 (en) 2001-09-24
WO2001068801A3 (en) 2002-02-07
EP1272609A4 (de) 2004-12-22
EP1272609A2 (de) 2003-01-08
WO2001068801A2 (en) 2001-09-20
US7288637B2 (en) 2007-10-30
EP1272609B1 (de) 2007-02-07
US6630584B1 (en) 2003-10-07
DE60126482T2 (de) 2007-11-29
US20030022244A1 (en) 2003-01-30
DE60126482D1 (de) 2007-03-22

Similar Documents

Publication Publication Date Title
ATE353335T1 (de) Einkettige antikörper gegen eine p53 mutante
CY1122505T1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn
CY2019029I1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
DE60142614D1 (de) Inität
UA87093C2 (ru) ГУМАНИЗИРОВАННЫЙ ИММУНОГЛОБУЛИН, КОТОРЫЙ СПЕЦИФИЧЕСКИ СВЯЗЫВАЕТСЯ С БЕТА-АМИЛОИДНЫМ ПЕПТИДОМ (Аβ)
CY1118462T1 (el) Μονοκλωνικο αντισωμα κατα της πρωτεϊνης συνδεσης οστεοπροτεγερινης
HUP0302128A2 (hu) Anti-duális-integrin ellenanyagok, készítmények, eljárások és alkalmazások
AT500379B1 (de) Tau-proteine
WO2004032868A3 (en) Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof
CY1108545T1 (el) Πρωτεϊνες υπομοναδας υποδοχεα κυτοκινης θηλαστικου, σχετικα αντιδραστηρια και μεθοδοι
CA2469833A1 (en) Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them
WO2007067730A3 (en) Human monoclonal antibodies to protein tyrosine kinase 7 ( ptk7 ) and their use
NO20025450D0 (no) Ny farmasöytisk sammensetning
MXPA05001841A (es) Formulacion de anticuerpos humanos para tratar trastornos asociados con tnfa.
EA200700083A1 (ru) Антитела, направленные против бета-амилоидного пептида, и способы их применения
DE122012000001I1 (de) Humane antikorper gegen CTLA-4 und deren verwendungen.
CY1111237T1 (el) Χρηση πραμιπεξολης για αντιμετωπιση αμυοτροφικης πλευρικης σκληρυνσης
DE60237778D1 (de) Antikörper gegen kdr, deren herstellung und verwendungen
ATE366746T1 (de) Gegen das semp1-protein gerichtete antikörper, verfahren zu deren herstellung, und deren anwendungen
WO2007124133A3 (en) Methods and compositions based on shiga toxin type 1 protein
JP2004510683A5 (de)
ATE362490T1 (de) Monoklonale antikörper gegen den menschlichen ldl-rezeptor, deren herstellung und verwendung
ATE393170T1 (de) Humanisierter antikörper gegen fibroblastenwachstumsfaktor 8 und fragment des antikörpers
ATE482980T1 (de) Antikörper variable region eines monoklonalen antikörpers gegen den humanen tumor nekrose faktor-alpha und dafür kodierendes gen
AU2002350406A1 (en) Identification of ses-3 (spr-5) in c. elegans and the uses of the same

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties